Effect of weight gain on blood pressure in Ugandan persons with HIV on dolutegravir/lamivudine/ tenofovir disoproxil fumarate over 48 weeks
PLOS One · 2025
DOI: 10.1371/journal.pone.0325020 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Willington Amutuhaire und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine, Department of Cardiology, Connecticut, United States of America. Hauptthemen laut MEDLINE: Weight Gain, Heterocyclic Compounds, 3-Ring, HIV Infections, Tenofovir. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, Fogarty International Center, Center for AIDS Research, University of California, San Diego.
Abstract (Originalsprache)
Background
Most people living with HIV in low and middle-income countries are taking fixed dose combination tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD). Dolutegravir use has been associated with weight gain, a known risk factor for hypertension. We aimed to determine if weight gain in Ugandan anti-retroviral therapy (ART) naïve patients on TLD correlated with increase in blood pressure.
Methods
We analyzed data from the ‘Glucose metabolism changes in Ugandan persons with HIV (PLHIV) on Dolutegravir (GLUMED)’ study which was a prospective cohort study with ART naïve persons with HIV ≥ 18 years followed up on TLD over 48 weeks. A scatter plot with 95% confidence intervals and regression line illustrating the relationship between weight change and mean arterial pressure (MAP) change from baseline to 48 weeks was created. To further examine the effect of weight change on MAP, we performed a linear regression analysis, with MAP change as the dependent variable and weight change as the independent variable.
Results
Of the 220 patients’ data analyzed, 129 (58.6%) were female, the median baseline age was 31 years (interquartile range (IQR): 27.0–38.0), the median baseline CD4 cell count was 319 cells/mm 3 (IQR 160.0–524.0). The median weight gain over 48 weeks was 3.0 (IQR: −0.1–6.3). We found a moderate positive linear relationship between weight gain and MAP over 48 weeks. For every increase in weight of 1 kg over 48 weeks, there was an adjusted increase in MAP by 0.62mmHG.
Conclusion
We provide additional evidence to suggest that the noticed weight gain after starting dolutegravir based ART may be associated with a heightened risk of incident hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Yale School of Medicine, Department of Cardiology, Connecticut, United States of America.
- Infectious Diseases Institute, Makerere University Kampala, Uganda.
- Global Health Institute, Antwerp University, Antwerp, Belgium.
- Department of Women's and Children's Health, Tumour and Cell Biology, Karolinska University, Sweden.
- Makerere University Johns Hopkins Collaboration, HIV clinic, Kampala, Uganda.
- United Health Services, Wilson Hospital, Department of Internal Medicine, New York, United States of America.
ORCID-Profile: Nele Brusselaers, Bridgette Nixon, Frank Mulindwa
Förderung
- FIC NIH HHS
- Fogarty International Center
- Center for AIDS Research, University of California, San Diego
Zitieren
APA
Amutuhaire, W., Castelnuovo, B., Brusselaers, N., Nabwana, M., Muhammad, L., Maloney, B., Nixon, B., Schwarz, J. M., & Mulindwa, F. (2025). Effect of weight gain on blood pressure in Ugandan persons with HIV on dolutegravir/lamivudine/ tenofovir disoproxil fumarate over 48 weeks. PLOS One. https://doi.org/10.1371/journal.pone.0325020
Vancouver
Amutuhaire W, Castelnuovo B, Brusselaers N, Nabwana M, Muhammad L, Maloney B, et al. Effect of weight gain on blood pressure in Ugandan persons with HIV on dolutegravir/lamivudine/ tenofovir disoproxil fumarate over 48 weeks. PLOS One. 2025. doi:10.1371/journal.pone.0325020
BibTeX
@article{Amutuhaire2025,
author = {Amutuhaire, Willington and Castelnuovo, Barbara and Brusselaers, Nele and Nabwana, Martin and Muhammad, Lal and Maloney, Brendan and Nixon, Bridgette and Schwarz, Jean-Marc and Mulindwa, Frank},
title = {Effect of weight gain on blood pressure in Ugandan persons with HIV on dolutegravir/lamivudine/ tenofovir disoproxil fumarate over 48 weeks},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0325020}
}
EUVIMED